Prof Dr. Ali Shayanfar|Pharmaceutical Chemistry |Best Researcher Award

Posted on by sciencefather

Prof Dr. Ali Shayanfar|Pharmaceutical Chemistry |Best Researcher Award|

Prof Dr. Ali Shayanfar at abriz University of Medical Sciences, Iran

PROFILE  

Google scholar

Early Academic Pursuits 🎓

Shayan Fara began his academic journey at the Faculty of Pharmacy, Tabriz University of Medical Sciences, where he earned his Pharm.D. from 2003 to 2009. During these formative years, he developed a strong foundation in pharmaceutical sciences, laying the groundwork for his future career. His passion for pharmaceutical chemistry drove him to pursue a Ph.D. in the same field at Tabriz University of Medical Sciences from 2009 to 2013. His doctoral research focused on the solid-state and solution chemistry of drugs, an area that would later become a central theme of his research.

Professional Endeavors and Career Growth 🏢

After completing his Ph.D., Dr. Fara joined the Faculty of Pharmacy at Tabriz University of Medical Sciences as an Assistant Professor of Pharmaceutical Chemistry in 2014. His dedication to teaching and research led to a steady rise in his academic career. By 2018, he had been promoted to Associate Professor, and in 2023, he reached the pinnacle of his academic career by becoming a full Professor of Pharmaceutical Chemistry.

Dr. Fara’s professional endeavors extend beyond teaching. He has held several key administrative positions, including serving as the Secretary and Research Secretary of the Student Research Committee at Tabriz University of Medical Sciences. His leadership skills and commitment to research were further recognized when he became the Head of the Student Research Committee from 2018 to 2020.

Contributions and Research Focus 🧪

Dr. Fara’s research interests are diverse and impactful, focusing on the solid-state and solution chemistry of drugs, pharmaceutical and biomedical analysis, and modeling in pharmaceutical sciences. He has made significant contributions to understanding the physical and chemical properties of drugs in both solid and solution states. His work in this area has implications for drug formulation, stability, and bioavailability, making it crucial for the development of more effective pharmaceutical products.

His expertise extends to various analytical techniques, including UV-Vis spectrophotometry, HPLC, spectrofluorimetry, FT-IR, DSC, and PXRD. He has also conducted extensive research in chemometrics, molecular modeling, QSAR and QSPR studies, solubility and dissolution rate determination techniques, and crystallization of drugs. His technical prowess in these areas has enabled him to contribute to the advancement of pharmaceutical sciences, both in theory and practice.

Accolades and Recognition 🏆

Throughout his career, Dr. Fara has received numerous accolades and recognition for his contributions to pharmaceutical sciences. His role as an editor in several prestigious journals, including being the Editor-in-Chief of the Pharmaceutical Sciences Journal since 2020, highlights his influence in the field. He has also served as an Associate Editor for the Pharmaceutical Sciences Journal from 2014 to 2020 and for the Directory of Open Access Journals (DOAJ) from 2017 to 2018.

His editorial roles, combined with his contributions to research, have earned him a place on the editorial boards of several high-impact journals, including Pharmaceutical Sciences and ImmunoAnalysis. His involvement with these journals not only showcases his expertise but also his commitment to advancing the quality and accessibility of scientific knowledge.

Impact and Influence 🌍

Dr. Fara’s impact on the field of pharmaceutical sciences is profound. His research has influenced the development of new analytical methods and drug formulations, contributing to the broader field of pharmaceutical chemistry. His work in modeling and chemometrics has provided valuable insights into the relationship between drug properties and their therapeutic efficacy.

In addition to his research contributions, Dr. Fara has been instrumental in mentoring the next generation of pharmaceutical scientists. His teaching experience spans various subjects, including Analytical Chemistry, Medicinal Chemistry, Instrumental Analysis, General Chemistry, Medical Information Systems, Research Methods, Endnote Software, and Ethics in Publication. His dedication to education ensures that his influence will extend far beyond his direct contributions to research.

Legacy and Future Contributions 🌟

As Dr. Fara continues his career as a Professor of Pharmaceutical Chemistry, his legacy is already being built through his research, teaching, and editorial work. His ongoing contributions to the field, particularly in the areas of drug analysis and modeling, will continue to shape the future of pharmaceutical sciences. His commitment to excellence in research and education, combined with his leadership in various academic and editorial roles, ensures that his impact will be felt for years to come.

🎓Publication 

Solubility of carvedilol in ethanol+ propylene glycol mixtures at various temperatures

  • Authors   :Sahel Vahdati, Ali Shayanfar, Jalal Hanaee, Fleming Martínez, William E Acree Jr, Abolghasem JouybanA et al...
  • Journal    :Industrial & Engineering Chemistry Research
  • Year         :2013

Review of pharmaceutical applications of N-methyl-2-pyrrolidone

  • Authors   :Abolghasem Jouyban, Mohammad Amin Abolghasemi Fakhree, Ali Shayanfar
  • Journal    :Journal of Pharmacy & Pharmaceutical Sciences
  • Year         :2010

Deep eutectic solvents for pharmaceutical formulation and drug delivery applications

  • Authors   :Shahram Emami, Ali Shayanfar
  • Journal    :Pharmaceutical development and technology
  • Year         :2020

Effect of choline chloride/ethylene glycol or glycerol as deep eutectic solvents on the solubility and thermodynamic properties of acetaminophen

  • Authors   : Hemayat Shekaari, Mohammed Taghi Zafarani-Moattar, Ali Shayanfar, Masumeh Mokhtarpour
  • Journal    :Journal of Molecular Liquids
  • Year         :2018

Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy

  • Authors   :Ommoleila Molavi, Farzaneh Narimani, Farshid Asiaee, Simin Sharifi, Vahideh Tarhriz, Ali Shayanfar, Mohammadsaied Hejazi, Raymond Lai
  • Journal    : Pharmaceutical biology
  • Year         :2017

Assoc Prof Dr. Mohammed Saddik |Formulation Science |Best Researcher Award

Posted on by sciencefather

Assoc Prof Dr. Mohammed Saddik|Formulation Science |Best Researcher Award|

Assoc Prof Dr. Mohammed Saddik atFaculty of Pharmacy, Sohag University, Egypt

PROFILE  

 

Orcid

Early Academic Pursuits 🎓

Mohammed Sherif Saddik Ibrahim began his academic journey with a strong foundation in pharmaceutical sciences. He earned his Bachelor of Pharmaceutical Sciences from the Faculty of Pharmacy, Assiut University, Egypt, on July 22, 2006. His dedication to the field was evident early on, as he quickly advanced to pursue postgraduate studies. By July 24, 2011, he had obtained his Master’s degree in Pharmaceutical Sciences, specializing in pharmaceutics. His master’s thesis, titled “Formulation and Clinical Evaluation of Some Topical Pharmaceutical Dosage Forms of Phenytoin,” highlighted his interest in the clinical applications of pharmaceuticals. Not stopping there, Mohammed continued his academic pursuits, earning a Doctor of Pharmaceutical Sciences (Ph.D.) in Pharmaceutics from Assiut University on January 24, 2017. His doctoral research focused on the “Formulation and Clinical Evaluation of Some Topical Pharmaceutical Dosage Forms of Methylene Blue for Photodynamic Therapy,” showcasing his commitment to innovative therapeutic solutions.

Professional Endeavors 🧑‍🏫

Dr. Mohammed Sherif Saddik Ibrahim’s professional career is marked by his continuous advancement in academia and clinical practice. He began as a Pharmacist at Al-Azhar University Hospital, Faculty of Medicine, Assiut University, where he worked from July 24, 2007, to October 11, 2014. This role allowed him to gain practical experience in the pharmaceutical field, which he later integrated into his teaching and research.

In 2014, Mohammed transitioned to an academic role at Sohag University, Egypt, where he served as an Assistant Lecturer of Pharmaceutics and Clinical Pharmacy until February 26, 2017. Following his Ph.D., he was promoted to Lecturer in the same department, a position he held until June 27, 2022. His excellence in teaching and research led to his appointment as an Associate Professor of Pharmaceutics and Clinical Pharmacy at Sohag University on June 29, 2022, where he continues to contribute to the field. Additionally, since September 13, 2022, Mohammed has been coordinating the Clinical Pharmacy Program at Sohag University, further cementing his role as a leader in pharmacy education.

Contributions and Research Focus 💡

Dr. Mohammed Sherif Saddik Ibrahim’s research is centered around the formulation and clinical evaluation of pharmaceutical dosage forms. His work has significant implications for enhancing the therapeutic efficacy of drugs and improving patient outcomes. One of his notable research contributions includes the development of topical pharmaceutical dosage forms for photodynamic therapy, specifically using methylene blue. This research is particularly important for its potential in treating various skin conditions and diseases through non-invasive methods.

Mohammed’s innovative approach is also evident in his work on drug delivery systems. He has supervised multiple postgraduate students, guiding them in research that explores novel drug formulations and delivery methods. His expertise in handling lab animals and conducting clinical studies further supports his research goals, particularly in designing dosage forms that are both effective and patient-friendly.

Accolades and Recognition 🏆

Throughout his career, Dr. Mohammed Sherif Saddik Ibrahim has received recognition for his contributions to pharmaceutical sciences. His work has led to several patents, including those for sulfasalazine-loaded zinc oxide nanoparticles for the treatment of ulcerative colitis (US11730759B1) and a polymeric clotrimazole biofilm for the treatment of otomycosis (US11844781B1). These patents reflect his innovative thinking and commitment to developing new therapeutic solutions.

His academic contributions have also been recognized through his participation in significant conferences. Notably, he presented at the NUB 2nd Conference of Scientific Research in Pharmacy Future Insight at the Faculty of Pharmacy, Nahda University, in March 2019, and the 1st Conference of Pharmaceutical Sciences at Badr University in Cairo, held online in November 2021. These platforms allowed him to share his research findings with the broader scientific community and gain insights into the latest developments in pharmaceutical sciences.

Impact and Influence 🌍

Dr. Mohammed Sherif Saddik Ibrahim’s impact on the field of pharmaceutics extends beyond his research. As an educator, he has taught a wide range of courses at Sohag University, including Pharmaceutics, Physical Pharmacy, Community Pharmacy, Controlled Drug Delivery, and Pharmaceutical Legislations & Regulatory Affairs. His teaching not only imparts knowledge but also inspires the next generation of pharmacists and researchers. Mohammed’s role as a coordinator of the Clinical Pharmacy Program at Sohag University further amplifies his influence, as he shapes the curriculum and ensures that students receive a comprehensive and up-to-date education.

His contributions to research have also had a tangible impact on patient care. The dosage forms and drug delivery systems he has developed have the potential to improve the treatment of various conditions, from skin diseases to chronic illnesses like ulcerative colitis. By focusing on patient-centered research, Mohammed’s work is helping to bridge the gap between laboratory research and clinical practice, ultimately benefiting patients in Egypt and beyond.

Legacy and Future Contributions 🚀

As a progressive professional with a strong research background, Dr. Mohammed Sherif Saddik Ibrahim is poised to continue making significant contributions to the field of pharmaceutical sciences. His commitment to education and research, particularly in the area of drug delivery systems, positions him as a leader in the field. Looking ahead, Mohammed aims to further explore the green synthesis of nanomaterials and their application in drug delivery. His goal is to develop innovative pharmaceutical dosage forms that are not only effective but also environmentally sustainable.

Mohammed’s vision for the future includes expanding his research to address emerging medical challenges, such as diabetes and leukemia. With two patents already in progress for treatments in these areas, he is actively working towards solutions that could have a profound impact on global health. His determination to identify innovative approaches and improve medical outcomes drives his research and teaching efforts.

Conclusion 🌟

Dr. Mohammed Sherif Saddik Ibrahim’s career is a testament to his dedication to advancing pharmaceutical sciences. From his early academic pursuits to his current role as an Associate Professor and researcher, he has consistently sought to improve drug delivery systems and therapeutic efficacy. His contributions to education, research, and patient care have left a lasting impact, and his future work promises to bring even more innovative solutions to the field. As he continues to explore new frontiers in pharmaceutics, Mohammed’s legacy as a visionary educator and researcher will undoubtedly grow.

🎓Publication 

Formulation and evaluation of azithromycin-loaded silver nanoparticles for the treatment of infected wounds.

  • Authors   :Saddik MS; Al-Hakkani MF; Abu-Dief AM; Mohamed MS; Al-Fattah IA; Mahmoud Makki; El-Mokhtar MA; Marwa A. Sabet; Amin MS; Ahmed HA et al...
  • Journal    :pharmaceutics
  • Year         :2024

Characterization and Bio-Evaluation of the Synergistic Effect of Simvastatin and Folic Acid as Wound Dressings on the Healing Process

  • Authors   : Mahmoud A. Hashem; Badriyah S. Alotaibi; Mahmoud M.A. Elsayed; Manal E. Alosaimi; Amal K. Hussein; Maram Abduljabbar; Kyung-Tae Lee; Hamdy Abdelkader; Mohamed A. El-Mokhtar ; Ahmed Hassan et al.
  • Journal    :Pharmaceutics
  • Year         :2023

Synthesis, Physicochemical Characterization using a Facile Validated HPLC Quantitation Analysis Method of 4-Chloro-phenylcarbamoyl-methyl Ciprofloxacin and Its Biological Investigations

  • Authors   :Mostafa F. Al-Hakkani; Nourhan Ahmed; Alaa A. Abbas; Mohammad H. A. Hassan; Hossameldin A. Aziz; Ali M. Elshamsy; Hazim O. Khalifa; Mohamed A. Abdelshakour; Mohammed S. Saddik; Mahmoud M. A. Elsayed et al.
  • Journal    :Molecular Sciences
  • Year         :2023

Development of Novel Nano-Sized Imine Complexes Using Coriandrum sativum Extract: Structural Elucidation, Non-Isothermal Kinetic Study, Theoretical Investigation and Pharmaceutical Applications

  • Authors   : Shimaa Hosny; Randa F. Abd El-Baki; Zeinab H. Abd El-Wahab; Gamal A. Gouda; Mohammed S. Saddik; Ateyatallah Aljuhani; Ahmed M. Abu-Dief.
  • Journal    :Molecular Sciences
  • Year         :2023

In vitro and in vivo synergistic wound healing and anti-methicillin-resistant Staphylococcus aureus (MRSA) evaluation of liquorice-decorated silver nanoparticles

  • Authors   :Hamdoon Mohammed; Mohammed A. Amin; Gamal Zayed; Yassar Hassan; Mohamed El-Mokhtar; Mohammed S. Saddik..
  • Journal    : Antibiotics
  • Year         :2023

Prof. Anca Oana Hermenean |Pharmacology |Best Innovation Award

Posted on by sciencefather

Prof. Anca Oana Hermenean|Pharmacology |Best Innovation Award|

Prof. Anca Oana Hermenean at Vasile Goldis Western University of Arad, Romania

PROFILE  

scopus

Orcid

Early Academic Pursuits 📚

Prof. Dr. Anca Hermenean began her academic journey at Babes-Bolyai University of Cluj-Napoca, Romania, where she earned her Bachelor’s degree in Biology from 1989 to 1994. This foundational education set the stage for her extensive career in biochemistry and molecular biology. Her academic prowess continued to shine as she pursued a PhD in Biology from 1997 to 2003, focusing on electron microscopy, histopathology, and immunohistochemistry. This period of intense study was marked by rigorous research and a commitment to understanding the microscopic and molecular mechanisms underlying various biological processes.

Professional Endeavors 🏛️

Prof. Hermenean’s professional career is distinguished by her roles in academia and research management. Since 2010, she has served as a Professor at the Faculty of Medicine, Vasile Goldis Western University of Arad (VGWU), where she has made significant contributions to the fields of histology and cell biology. Her expertise in these areas is evidenced by her ongoing research and teaching responsibilities.

In 2016, Prof. Hermenean was appointed Director of the VGWU Doctoral Studies Council, a role in which she has overseen the management and strategic development of doctoral programs in Medicine and Biology. Her leadership extended further in 2017 when she joined the Faculty of Engineering in Foreign Languages at Politehnica University of Bucharest, contributing to the Master Program in Biomaterials for Tissue Engineering. She has taught various courses related to cell and tissue biology, tissue regeneration, and debilitating diseases of tissue.

In 2020, Prof. Hermenean became the Director of the Life Science Institute and Principal Investigator at the Institute of Life Sciences, VGWU. Here, she manages research projects and oversees activities in microscopy labs and the animal facility, reflecting her deep engagement in both research and administration.

Contributions and Research Focus 🔬

Prof. Hermenean’s research contributions are broad and impactful, focusing on several key areas:

  1. Histology and Histopathology: Her work in these fields explores the microscopic structure of tissues and the pathological changes associated with various diseases. This includes significant contributions to understanding how cellular and tissular alterations can affect health.
  2. Phytomedicine: Prof. Hermenean has researched the modulation of signal transduction pathways by phytochemicals, their molecular regulation of anti-inflammatory and anti-fibrotic responses, and their interactions with drugs and chemicals.
  3. Nanobiotechnology: She has been involved in the characterization of bio-interfaces and in vivo biocompatibility studies of nanomaterials. Her work includes assessing the interactions between nanomedicines and biological systems, as well as evaluating structural and ultrastructural toxicological effects.
  4. Regenerative Medicine: Prof. Hermenean’s research also covers tissue repair and regeneration pathways, focusing on molecular signals, growth factors, and the mechanisms of tissue regeneration.

Accolades and Recognition 🏆

Prof. Hermenean’s work has garnered significant recognition within the scientific community. She holds a habilitation in Biology, a postdoctoral qualification that allows her to supervise PhD candidates. Her research has led to numerous publications in peer-reviewed journals, with an H-index of 30 on Scopus and 34 on Google Scholar. Additionally, she has been awarded several patents for her innovations in pharmaceutical compositions and drug delivery systems, underscoring her contributions to practical and applied sciences.

Impact and Influence 🌍

Prof. Hermenean’s influence extends beyond her research and teaching. Her roles in managing research councils and institutes highlight her ability to shape research strategies and educational programs. Her contributions have had a tangible impact on the advancement of biomedical sciences, particularly in the fields of histology, nanobiotechnology, and regenerative medicine.

Her work on phytomedicine and nanobiotechnology is particularly notable for its potential applications in developing new therapeutic approaches and improving existing medical treatments. Her patents and research projects reflect her commitment to translating scientific discoveries into practical solutions.

Legacy and Future Contributions 🔮

Prof. Hermenean’s legacy is marked by her dedication to advancing scientific knowledge and training the next generation of researchers. Her leadership in establishing and managing research infrastructures, such as the animal facility and microscopy labs at VGWU, demonstrates her commitment to fostering a supportive environment for cutting-edge research.

Looking ahead, Prof. Hermenean is poised to continue making significant contributions to her fields of expertise. Her ongoing research and collaborations are expected to yield further advancements in phytomedicine, nanobiotechnology, and regenerative medicine. Her role as a mentor and educator will also play a crucial part in shaping future research and development in these areas.

🎓Publication 

Chrysin-loaded calixarene-cyclodextrin ternary drug delivery system inhibits TGF-β and galectin-1 mediated pathways in diabetic liver

  • Authors   :Balta, C., Herman, H., Ciceu, A., … D’Amico, M., Hermenean, A..
  • Journal    :Biochemical Pharmacology
  • Year         :2024

Dexmedetomidine improves the circulatory dysfunction of the glymphatic system induced by sevoflurane through the PI3K/AKT/ΔFosB/AQP4 pathway in young mice

  • Authors   :Wang, S., Yu, X., Cheng, L., … Lu, Y., Wu, X..
  • Journal    :Cell Death and Disease
  • Year         :2024

Exploring In Vivo Pulmonary and Splenic Toxicity Profiles of Silicon Quantum Dots in Mice

  • Authors   :Cristian, R.-E., Balta, C., Herman, H., … Dinischiotu, A., Stan, M.S..
  • Journal    :Materials.
  • Year         :2024

Ketamine administration causes cognitive impairment by destroying the circulation function of the glymphatic system

Colloidal and Biological Characterization of Dual Drug-Loaded Smart Micellar Systems

  • Authors   :Herman, H., Rata, D.M., Cadinoiu, A.N., Atanase, L.I., Hermenean, A..
  • Journal    :Polymers
  • Year         :2024

Prof Dr. Abhijit Chaudhury |Antibiotic Resistance| Best Researcher Award

Posted on by sciencefather

Prof Dr. Abhijit Chaudhury|Antibiotic Resistance|Best Researcher Award|

Prof Dr. Abhijit Chaudhury at SV INstitute of Medical Sciences, India

PROFILE  

scopus

Orcid

Early Academic Pursuits 🎓

Dr. Abhijit Chaudhury’s journey into the field of microbiology began with a strong academic foundation. He earned his MBBS from the esteemed Medical College, Calcutta, where he developed a keen interest in the microscopic world and its implications on human health. His pursuit of medical education led him to the Institute of Medical Sciences (IMS), Banaras Hindu University (BHU), Varanasi, where he completed his MD. These early years of rigorous training equipped Dr. Chaudhury with the knowledge and skills necessary to excel in the field of microbiology, setting the stage for a distinguished career in academia and research.

Professional Endeavors and Teaching Experiences 🌍

Dr. Chaudhury’s professional journey is marked by a rich and diverse teaching career spanning multiple countries and institutions. As a Professor of Microbiology at Sri Venkateswara Institute of Medical Sciences and Sri Padmavathi Medical College for Women in Tirupati, he has played a pivotal role in shaping the minds of future medical professionals. His teaching experiences extend beyond India, having taught in Nepal, Mauritius, Oman, and the Netherlands Antilles. This international exposure has not only broadened his own perspectives but has also enriched the learning experiences of his students, who benefit from his global insights and expertise.

Contributions and Research Focus 🔬

Dr. Chaudhury’s contributions to the field of microbiology are significant and far-reaching. He has authored nearly 100 papers in indexed journals, showcasing his commitment to advancing scientific knowledge. His research primarily focuses on tropical parasitology, a field in which he is recognized as a Fellow of the Indian Academy of Tropical Parasitology (FIATP). His work has been instrumental in understanding and combating parasitic diseases that affect millions in tropical regions.

In addition to his research papers, Dr. Chaudhury has contributed seven book chapters published by renowned publishers such as Wiley and Springer. His role as Co-Editor of the “Textbook of Parasitic Zoonoses,” published by Springer Nature, further underscores his expertise and leadership in the field. This textbook serves as a critical resource for researchers and healthcare professionals dealing with parasitic infections transmitted from animals to humans.

Accolades and Recognition 🏆

Dr. Chaudhury’s expertise has not gone unrecognized. He has been an active participant in various national and state conferences, where he has presented his research and shared his knowledge through lectures. His work has also gained international recognition, with invitations to present papers at conferences in Europe, Canada, and the USA. These accolades highlight his status as a respected figure in the global scientific community.

His role as a reviewer of the Antibiotic Treatment Guidelines for the Government of West Bengal is a testament to his expertise and trustworthiness in the field. Furthermore, his contributions to the National Task Force on Curriculum Development for the Medical Lab Technology course have had a lasting impact on medical education in India.

Leadership and Community Impact 🤝

Dr. Chaudhury has also made significant contributions to professional organizations. As an executive member of the Indian Academy of Tropical Parasitology (IATP), he has been instrumental in promoting the study and control of parasitic diseases in India. His efforts led to the establishment of the Andhra Pradesh chapter of IATP in 2013, where he has continued to serve as a guiding force. In November 2022, he served as the President of the State Chapter Conference of IATP, further demonstrating his leadership and commitment to the field.

His tenure as the Chief Managing Editor of the “Tropical Parasitology” journal underscores his influence in academic publishing. Under his leadership, the journal flourished, providing a platform for researchers to publish their findings and contribute to the global understanding of parasitic diseases.

Impact and Influence 🌟

Dr. Chaudhury’s impact on the field of microbiology, particularly in tropical parasitology, is profound. His research has contributed to a better understanding of parasitic diseases, which disproportionately affect tropical regions. His work has not only advanced scientific knowledge but has also influenced public health policies, particularly in the development of treatment guidelines.

His influence extends to the many students he has mentored over the years, both in India and abroad. His dedication to teaching and research has inspired a new generation of microbiologists who are now contributing to the field in their own right.

Legacy and Future Contributions 🌱

As Dr. Chaudhury continues his work, his legacy is already taking shape. His contributions to research, education, and public health will have a lasting impact on the field of microbiology. The textbooks and research papers he has authored will continue to serve as valuable resources for future generations of scientists and healthcare professionals.

Looking to the future, Dr. Chaudhury is likely to remain a key figure in microbiology and tropical parasitology. His ongoing research and participation in international conferences suggest that he will continue to contribute valuable insights and advancements to the field. As he builds on his impressive body of work, Dr. Chaudhury’s legacy will be one of dedication, leadership, and a relentless pursuit of knowledge.

Conclusion 🌍

Dr. Abhijit Chaudhury’s career is a shining example of excellence in microbiology. From his early academic pursuits to his professional endeavors, his contributions to research, education, and public health have left an indelible mark on the field. His leadership and influence have shaped the study of tropical parasitology in India and beyond, ensuring that his legacy will endure for years to come.

🎓Publication 

In vitro activity of the newly approved antimicrobial agent Cefiderocol against Carbapenem resistant Gram negative clinical isolates

Molecular diversity of Mycobacterium tuberculosis isolates in Treatment-experienced Patients from Andhra Pradesh, India

Prevalence of histidine‑rich protein 2 deletion among the Plasmodium falciparum isolates from Kolkata

  • Authors   :Acharya, A., Saha, P., Chaudhury, A., Guha, S.K., Maji, A.K.L.
  • Journal    :Tropical Parasitology
  • Year         :2023

Molecular Characterization and Identification of Potential Inhibitors for ‘E’ Protein of Dengue Virus

  • Authors   :Racherla, R.G., Katari, S.K., Mohan, A., … Kante, M., Kalawat, U..
  • Journal    :Viruses
  • Year         :2022

Sir U.N. Brahmachari and his battle against Kala-Azar

  • Authors   :Saha, P., Chaudhury, A., Maji, A.K..
  • Journal    :Tropical Parasitology
  • Year         :2021

Dr.Long Pang |Oncology Pharmaceuticals| Best Researcher Award-1332

Posted on by sciencefather

Dr.Long Pang|Oncology Pharmaceuticals |Best Researcher Award|

Dr.Long Pang at Xi’an Medical University, China

PROFILE  

scopus

Early Academic Pursuits 📚

Long Pang was born in Gansu, China, where he developed an early passion for science and innovation. His academic journey began with a focus on veterinary science, where he pursued a Master of Science (M.S.) degree at Northwest Agricultural and Forestry University in Yangling, Shaanxi, China. Completing his M.S. in July 2012, Pang demonstrated an exceptional commitment to his studies and research in veterinary science, laying the groundwork for his future endeavors in animal biotechnology. In August 2012, he advanced his academic career by enrolling in a Ph.D. program at the same university. During his Ph.D. studies, he specialized in Animal Biotechnology, a field that encompasses the use of biotechnological tools for the improvement of animal health and productivity. He completed his Ph.D. in July 2016, marking the beginning of a promising career in biomedical research.

Professional Endeavors 🏢

After earning his Ph.D., Long Pang joined Xi’an Medical University as an Associate Professor in the School of Basic Medical Science. His professional career is distinguished by his innovative research in the areas of microfluidics and single-cell analysis. At Xi’an Medical University, Pang quickly established himself as a leading researcher, focusing on the development of microfluidic chips and their applications in single-cell analysis and organ-on-a-chip technology. His work has been instrumental in advancing the understanding of cellular mechanics and tumor microenvironments, contributing significantly to the fields of biomedical engineering and cancer research.

Contributions and Research Focus 🔬

Long Pang’s research primarily revolves around microfluidics-based single-cell analysis and organ-on-a-chip technologies. His work has led to the development of innovative microfluidic devices that allow for the manipulation and analysis of single cells in a highly controlled environment. These devices have broad applications in cancer research, particularly in studying tumor microenvironments and the behavior of cancer stem cells. One of his significant contributions includes the development of a microfluidic chip for glioma stem cell sorting and single-cell-derived tumor sphere assays. This research has provided valuable insights into the formation of tumor spheres and the role of the tumor microenvironment in cancer progression.

Pang has also been involved in projects aimed at integrating microfluidic platforms with other technologies to enhance the precision and efficiency of single-cell analysis. His research has been supported by several prestigious grants, including those from the National Science Foundation of China and the Fundamental Research Foundation of Xi’an Medical University. Notably, he has led projects such as the study of heterotypic single-cell-derived tumor-sphere formation using an integrated microfluidics platform, which has garnered significant attention and funding.

Accolades and Recognition 🏆

Long Pang’s contributions to the field of biomedical research have been widely recognized. His work has resulted in over 21 publications in high-impact journals, including TRAC-Trends in Analytical Chemistry, Analytical Chemistry, and Sensors & Actuators B: Chemical. He has also authored a chapter in the Handbook of Single-Cell Technologies, published by Springer, highlighting his expertise in digital microfluidics for single-cell manipulation and analysis. In addition to his publications, Pang has been granted two Chinese patents related to his innovations in microfluidic technology, further establishing his reputation as a leading researcher in his field.

Pang’s achievements have also been acknowledged through various editorial appointments. He has served as a Youth Editorial Board Member of Glioma and the E-Journal of Translational Medicine, where he has contributed to the advancement of research dissemination and knowledge sharing in the scientific community. His contributions to the academic community extend beyond research, as he is an active member of several professional organizations, including the Shaanxi Pharmacology Association, the Chinese Society of Micro-Nano Technology (CSMNT), and the Chinese Chemistry Society (CCS).

Impact and Influence 🌍

The impact of Long Pang’s research extends beyond academia. His work on microfluidic devices has the potential to revolutionize the way single-cell analysis is conducted, offering new tools for researchers and clinicians in the diagnosis and treatment of diseases, particularly cancer. His contributions to the development of organ-on-a-chip technology are also significant, providing a platform for more accurate and efficient drug testing, which could lead to more effective treatments for various diseases.

Pang’s research has influenced a new generation of scientists and engineers, inspiring them to explore the possibilities of microfluidics and its applications in biomedical research. His collaborations with other leading researchers and institutions, both in China and internationally, have further expanded the reach of his work, fostering innovation and knowledge exchange in the global scientific community.

Legacy and Future Contributions 🚀

Long Pang’s legacy in the field of biomedical research is characterized by his innovative approach to solving complex problems in cell biology and medicine. His contributions to the development of microfluidic technology and single-cell analysis tools have set new standards in the field, paving the way for future research and innovation. As he continues his work at Xi’an Medical University, Pang remains committed to advancing the frontiers of biomedical engineering, with a focus on developing new technologies that can improve human health and well-being.

Looking to the future, Long Pang’s ongoing research projects, such as the construction of a 3D microenvironment for single-cell level tumor cells, promise to yield further breakthroughs in our understanding of cancer and other diseases. His work is likely to continue to influence the field for years to come, as he mentors the next generation of researchers and contributes to the global effort to improve healthcare through technological innovation.

🎓Publication 

Tumor microenvironment-derived exosomes-assisted single-cell-derived tumor-sphere formation and drug-resistance by a microfluidic system

Construction of multiple concentration gradients for single-cell level drug screening

Droplets microfluidics platform—A tool for single cell research

Microfluidics-Based Single-Cell Research for Intercellular Interaction

Digital Microfluidics for Single Cell Manipulation and Analysis

  • Authors   :Pang, L., Ding, J., Fan, S.-K.
  • Journal    :Handbook of Single-Cell Technologies
  • Year         :2021

D. Mina Kiani |Endocrine Pharmacology| Best Researcher Award

Posted on by sciencefather

D. Mina Kiani|Endocrine Pharmacology |Best Researcher Award|

D. Mina Kiani at Arak university, Iran

PROFILE  

scopus

Early Academic Pursuits 🎓

Mina Kiani’s academic journey began with a deep passion for the biological sciences, particularly in understanding the intricate processes that govern cell biology and development. She pursued her Bachelor’s degree in Biology at a reputable university in Iran, where she developed a solid foundation in the life sciences. Eager to delve deeper into the complexities of human biology, she continued her education by obtaining a Master’s degree in Histology and Embryology from Razi University of Kermanshah. Her master’s thesis, which focused on the histological changes in embryonic development, showcased her keen interest in developmental biology and set the stage for her future research endeavors.

Driven by a desire to contribute to the scientific community, Mina Kiani pursued a Ph.D. in Cell Biology and Development at Arak University. During her doctoral studies, she embarked on a pioneering research project that explored the effects of the antidiabetic drug empagliflozin on the reproductive system of diabetic rats. This research was particularly significant as it addressed a previously unexplored area of study, highlighting her innovative approach to scientific research.

Professional Endeavors 🧪

After completing her Ph.D., Mina Kiani joined the faculty at Arak University as a lecturer, where she has since been dedicated to both teaching and research. Her role as an educator has allowed her to share her expertise in cell biology, histology, and embryology with the next generation of scientists. Kiani is highly regarded by her students for her ability to simplify complex concepts and her commitment to fostering a deep understanding of biological sciences.

In addition to her teaching responsibilities, Kiani has been actively involved in research. Her work primarily focuses on pharmacokinetics, endocrine pharmacology, and drug safety, with a particular interest in how various drugs affect reproductive health. Her research has led to significant findings in the field, particularly concerning the impact of empagliflozin on testicular tissue and sperm parameters in diabetic rats.

Contributions and Research Focus 🔬

Mina Kiani’s contributions to the field of pharmacology and reproductive biology are both profound and innovative. Her research on empagliflozin, a relatively new antidiabetic drug, has been groundbreaking. Recognizing the increasing prevalence of type 2 diabetes among young men, Kiani sought to understand how this drug affects male reproductive health—a critical area that had not been previously studied.

Her research revealed that empagliflozin has antioxidant, anti-apoptotic, and anti-inflammatory effects on the testicular tissue of diabetic rats. These findings are crucial as they suggest that the drug may mitigate some of the harmful effects of diabetes on male fertility, potentially offering new therapeutic avenues for patients. Kiani’s work has been published in the prestigious journal Biochemical Pharmacology, where her study, “Empagliflozin reduces the adverse effects of diabetes mellitus on testicular tissue in type 2 diabetic Rats: A stereological and biochemical study,” has garnered attention for its scientific rigor and clinical relevance.

Accolades and Recognition 🏆

Mina Kiani’s work has not gone unnoticed in the scientific community. Her innovative research on the effects of empagliflozin has earned her recognition as a leading researcher in her field. The publication of her study in a high-impact journal is a testament to the quality and significance of her research. Moreover, her dedication to teaching and her ability to inspire students have made her a respected figure at Arak University.

While Kiani has not yet received formal awards for her work, the impact of her research is evident in the scientific community’s response to her publications. Her study on empagliflozin has been cited by other researchers, further validating the importance of her findings.

Impact and Influence 🌍

Mina Kiani’s research has the potential to influence clinical practices related to the treatment of diabetes in young men. By shedding light on the effects of empagliflozin on reproductive health, her work could lead to more informed decisions regarding the prescription of this drug to diabetic patients, particularly those concerned with fertility. Additionally, her research contributes to a broader understanding of the relationship between diabetes and reproductive health, an area that is becoming increasingly important as the prevalence of diabetes continues to rise globally.

As an educator, Kiani has also made a significant impact on her students, many of whom have gone on to pursue careers in the biological sciences. Her ability to connect with students and her dedication to their academic and professional development have helped shape the next generation of researchers and healthcare professionals.

Legacy and Future Contributions 🌟

Mina Kiani’s legacy is one of innovation, dedication, and a commitment to advancing our understanding of pharmacology and reproductive health. Her pioneering research on empagliflozin has opened new avenues for exploration and has the potential to improve the lives of countless individuals living with diabetes. As she continues her research, Kiani is likely to make further contributions to the field, particularly in understanding how other antidiabetic drugs affect reproductive health.

Looking ahead, Kiani is poised to continue her work at the intersection of pharmacology and reproductive biology. She plans to expand her research to include studies on the long-term effects of empagliflozin and other antidiabetic drugs on reproductive health. Additionally, she aims to collaborate with other researchers and institutions to further explore the complex relationships between diabetes, pharmacology, and fertility.

🎓Publication 

Empagliflozin reduces the adverse effects of diabetes mellitus on testicular tissue in type 2 diabetic Rats: A stereological and biochemical study

  • Authors   :Kiani, M., Soleimani Mehranjani, M., Ali Shariatzadeh, M.
  • Journal    :Biochemical Pharmacology
  • Year         :2024

Sildenafil citrate ameliorates the adverse effects of cryopreservation on sperm quality in asthenozoospermic men

  • Authors   :Kohzadi, R., Cheraghi, E., Mehranjani, M.S., Shariatzadeh, M.
  • Journal    :Healthcare Materials
  • Year         :2024

Seamless Integration of Rapid Separation and Ultrasensitive Detection for Complex Biological Samples Using Multistage Annular Functionalized Carbon Nanotube Arrays

  • Authors   :Lihuang Li; Jialing Zhang; Zhengqi Jiao; Xi Zhou; Lei Ren; Miao Wang.
  • Journal    :Cryobiology
  • Year         :2023

The effect of platelet lysate on mouse ovarian structure, function and epigenetic modifications after autotransplantation

  • Authors   :Sanamiri, K., Soleimani Mehranjani, M., Shahhoseini, M., Shariatzadeh, S.M.A.
  • Journal    :Reproductive BioMedicine Online
  • Year         :2023

The therapeutic effect of co-administration of pentoxifylline and zinc in men with idiopathic infertility

Prof. Lei Ren |Drug Delivery Systems| Best Researcher Award-1331

Posted on by sciencefather

Prof. Lei Ren|Drug Delivery Systems |Best Researcher Award|

Prof. Lei Ren at mus alparslan university, Turkeys

PROFILE  

Orcid 

Early Academic Pursuits 📚

Lei Ren’s academic journey began in the vibrant city of Tianjin, where she pursued her Bachelor of Science in Material Science & Engineering at Tianjin University, graduating in 1990. This foundational period was marked by her strong dedication to understanding the principles of material science, a field that would later shape her illustrious career. Tianjin University’s rigorous curriculum provided Ren with a solid grounding in the fundamentals of material science, equipping her with the skills and knowledge to explore its applications in various domains.

Ren’s academic curiosity led her to pursue further education at Peking Union Medical College, one of China’s most prestigious institutions. In 1997, she earned her Master of Science in Biomedical Engineering, a field that bridged her interests in material science and its applications in medicine. This interdisciplinary approach was a hallmark of Ren’s early academic endeavors, reflecting her passion for integrating diverse fields of study to address complex scientific challenges.

Her pursuit of knowledge did not stop there. Ren continued her academic journey in Japan, where she completed her Ph.D. in Material Science at Okayama University in 2001. This period was crucial in shaping her research trajectory, as she delved into advanced materials and their potential biomedical applications. Her time in Japan also exposed her to a new scientific culture, broadening her perspective and fostering a global approach to research that would later define her career.

Professional Endeavors 🌟

Upon completing her doctoral studies, Ren embarked on a career that seamlessly blended research and academia. Her first professional role was as a Research Associate at the Institute of Biomedical Engineering, Chinese Academy of Medical Sciences, where she worked from 1990 to 1997. During this time, Ren honed her research skills, contributing to various projects that explored the interface between material science and biomedical engineering.

In 2001, Ren transitioned to a global stage, joining the Singapore-MIT Alliance at the National University of Singapore as a Research Fellow. This opportunity allowed her to collaborate with leading scientists from around the world, further enhancing her research capabilities and expanding her professional network. Her work during this period focused on cutting-edge biomedical engineering projects, laying the groundwork for her future contributions to the field.

In 2002, Ren returned to China to join the Research Center of Biomedical Engineering at the College of Medicine, Xiamen University, as an Associate Professor. Over the next five years, she played a pivotal role in advancing the center’s research agenda, mentoring students, and publishing influential papers. Her dedication and expertise earned her a promotion to full Professor in 2007, a position she holds to this day at the Department of Biomaterials, College of Materials, Xiamen University.

Contributions and Research Focus 🧬

Ren’s research has primarily focused on the development and application of biomaterials, particularly in the context of biomedical engineering. Her work has explored the synthesis and characterization of novel materials designed to interact with biological systems, with the goal of improving medical devices, implants, and tissue engineering applications.

One of her significant contributions to the field has been her research on biocompatible materials that can be used in medical implants. Ren’s work has helped advance the understanding of how materials interact with the human body, leading to the development of safer and more effective implants that reduce the risk of rejection and improve patient outcomes. Her research has also explored the use of biomaterials in tissue engineering, where she has contributed to the development of scaffolds that support the growth and regeneration of tissues.

In addition to her work on biomaterials, Ren has also been involved in interdisciplinary projects that integrate material science with other fields, such as nanotechnology and regenerative medicine. Her ability to bridge these diverse areas of study has positioned her as a leader in the field of biomedical engineering, with her work having a profound impact on both academic research and practical medical applications.

Accolades and Recognition 🏅

Throughout her career, Lei Ren has received numerous accolades in recognition of her contributions to the field of biomedical engineering. Her research has been widely published in leading scientific journals, earning her a reputation as a highly respected scholar in her field. Her work has also been recognized by various professional organizations, both in China and internationally, highlighting her status as a pioneering figure in the field of biomaterials.

Ren has been invited to speak at numerous international conferences, where she has shared her insights on the latest developments in biomaterials and biomedical engineering. These speaking engagements have not only showcased her research but also facilitated the exchange of ideas with other leading scientists, furthering the advancement of the field.

Impact and Influence 🌍

Ren’s influence extends beyond her research and academic roles. As a professor at Xiamen University, she has mentored numerous students who have gone on to make their own contributions to the field of biomedical engineering. Her commitment to teaching and mentorship has helped shape the next generation of scientists, ensuring that her impact will be felt for years to come.

Moreover, Ren’s work has had a tangible impact on the medical field. The biomaterials she has developed have been used in various medical devices and implants, improving the quality of life for patients around the world. Her interdisciplinary approach to research has also inspired new collaborations between scientists from different fields, leading to innovative solutions to some of the most pressing challenges in medicine.

Legacy and Future Contributions 🔮

As Lei Ren continues her work at Xiamen University, her legacy as a pioneer in the field of biomaterials is already well established. Her contributions to the development of biocompatible materials and her interdisciplinary approach to research have left an indelible mark on the field of biomedical engineering. Moving forward, Ren is likely to continue pushing the boundaries of what is possible in her field, exploring new frontiers in material science and its applications in medicine.

🎓Publication 

Oral biomimetic virus vaccine hydrogel for robust abscopal antitumour efficacy

  • Authors   :Chufan Wang; Haobo Tang; yufei Duan; Qiang Zhang; Wenjun Shan; Xiumin Wang; Lei Ren
  • Journal    :Colloid and Interface Science
  • Year         :2024

Tumor‐Associated Myeloid Cells Selective Delivery of a Therapeutic Tumor Nano‐Vaccine for Overcoming Immune Barriers for Effective and Long‐Term Cancer Immunotherapy

  • Authors   :Chufan Wang; Jinglian Zhao; Yufei Duan; Liping Lin; Qiang Zhang; Haiping Zheng; Wenjun Shan; Xiumin Wang; Lei Ren
  • Journal    :Healthcare Materials
  • Year         :2024

Seamless Integration of Rapid Separation and Ultrasensitive Detection for Complex Biological Samples Using Multistage Annular Functionalized Carbon Nanotube Arrays

  • Authors   :Lihuang Li; Jialing Zhang; Zhengqi Jiao; Xi Zhou; Lei Ren; Miao Wang.
  • Journal    :Materials
  • Year         :2024

Generalized Multifunctional Coating Strategies Based on Polyphenol-Amine-Inspired Chemistry and Layer-by-Layer Deposition for Blood Contact Catheters

  • Authors   :Jiahao Du; Xiaoting Zhang; Wenlong Li; Miao Wang; Xi Zhou; Lei Ren
  • Journal    :Biomaterials Science & Engineering
  • Year         :2024

Driving modes and characteristics of biomedical micro-robots

  • Authors   :Engineered Regeneration
    .

  • Journal    :Libing Huang; Yueyuan Pan; Miao Wang; Lei Ren
  • Year         :2023

Dr. Rahim Dehghan|Pharmaceutical Biotechnology| Best Researcher Award

Posted on by sciencefather

Dr. Rahim Dehghan|Pharmaceutical Biotechnology |Best Researcher Award|

Dr. Rahim Dehghan at mus alparslan university, Turkeys

PROFILE  

scopus

Google Sholar

 

Early Academic Pursuits 🎓

Rahim Dehghan embarked on his academic journey in the field of polymer engineering at Shiraz University, where he earned his bachelor’s degree in 2011. Driven by a deep curiosity and passion for polymer science, he pursued a master’s degree in polymer engineering at Yazd University, completing it in 2015. His master’s thesis was a significant exploration of blood-compatible membranes, a topic that laid the foundation for his future research endeavors. This period of academic training provided him with a robust understanding of polymer materials and their applications in biomedical engineering, particularly in the development of membranes for medical use.

Professional Endeavors and Research Focus 🧪

Dehghan’s professional career has been marked by a series of research positions and projects that have focused on the development and enhancement of synthetic membranes for biomedical applications. In 2016, he commenced his Ph.D. at the prestigious Iran Polymer and Petrochemical Institute, a leading center for polymer education in Iran. His doctoral research was centered on developing membranes for the separation of low-density lipoprotein (LDL), commonly known as bad cholesterol, from blood plasma. This work was groundbreaking, as it addressed critical challenges in blood purification technologies, aiming to improve the efficiency and efficacy of these processes.

During his Ph.D. studies, Dehghan worked on several key aspects of membrane engineering, including pore size optimization, morphology control, and enhancing membrane permeability. His innovative approach to membrane structural engineering was aimed at achieving high-performance membranes capable of selective separation of LDL from blood plasma, while ensuring high plasma permeability. His research contributions during this period culminated in a Ph.D. degree, awarded in 2022 with an excellent grade, reflecting the significance and quality of his work.

Contributions and Research Focus 🌍

Dehghan’s research has had a profound impact on the field of membrane science, particularly in the development of membranes for biomedical applications. His work on LDL separation has opened new avenues for research in blood purification technologies, with potential applications in treating cardiovascular diseases and other conditions where blood purification is critical. He has also contributed to the field of microfiltration membranes for plasmapheresis, a process used to separate plasma from blood cells. His recent work has successfully developed a microfiltration membrane capable of simultaneously separating LDL and blood cells from whole blood, a significant advancement in this area.

In addition to his academic research, Dehghan has played a crucial role in the industrial application of his findings. As a researcher at the Iranian Polymer and Petrochemical Institute and a senior researcher at D.G.DENA Co., he has applied his expertise to the development of biomedical devices, including hydrogels and gels for wound care. His work in these roles has involved the application of advanced polymer science to address real-world challenges in medical device manufacturing.

Accolades and Recognition 🏆

Throughout his academic and professional career, Dehghan has received numerous accolades that highlight his contributions to the field of polymer engineering. One of his early achievements was acquiring the 8th rank in the national Ph.D. entrance exam in Iran in 2016, a highly competitive examination with over 400 participants. This accomplishment not only earned him a prestigious scientific award but also set the stage for his successful academic career.

His research has been widely recognized and published in several leading international journals, including the Journal of Membrane Science and Separation and Purification Technology. These publications have not only disseminated his findings to the broader scientific community but have also established him as a leading researcher in the field of polymer-based membrane technologies.

Impact and Influence 🌟

Dehghan’s work has had a significant impact on both the academic and industrial sectors. His research on membrane technologies has provided new insights into the design and development of high-performance membranes for medical applications. These contributions are particularly important in the context of blood purification technologies, where efficient and selective separation processes are critical for patient outcomes.

In the industrial sphere, his work as a consultant and researcher has directly influenced the development of new medical devices, particularly in the area of wound care. His expertise in polymer science has been instrumental in advancing the capabilities of these devices, ensuring they meet the stringent requirements of biomedical applications.

Legacy and Future Contributions 🌠

Looking ahead, Rahim Dehghan’s contributions to the field of polymer engineering and membrane science are poised to leave a lasting legacy. His work has already set new standards for the development of synthetic membranes, particularly in the biomedical field. As he continues to explore new research opportunities, particularly in the field of blood purification membranes such as hemodialysis and hemodiafiltration, his impact on the field is expected to grow.

🎓Publication 

Dextran sulfate bulk and surface-modified microfiltration membrane for simultaneous blood plasma harvesting and low-density lipoprotein removal during plasmapheresis

  • Authors   :Dehghan, R., Barzin, J., Carbonell, R.G., Ghaderi Jafarbeigloo, H., Kordkatooli, Z.
  • Journal    :Journal of Membrane Science
  • Year         :2024

Evaluation of solubility parameters and relative energy difference (RED) on the preparation of polysulfone/polyethylene glycol membrane: A study on the casting solution and coagulation bath

Membrane patterning through horizontally aligned microchannels developed by sulfated chopped carbon fiber for facile permeability of blood plasma components in low-density lipoprotein apheresis

High cut-off membrane: evaluation of pore collapse and the synergistic effect of low and high molecular weight polyvinylpyrrolidone

Low density lipoprotein (LDL) apheresis from blood plasma via anti-biofouling tuned membrane incorporated with graphene oxide-modified carrageenan

Assist Prof Dr. AYŞEGÜL KILIÇLI|Clinical Trials| Best Researcher Award

Posted on by sciencefather

Assist Prof Dr. AYŞEGÜL KILIÇLI|Clinical Trials |Best Researcher Award|

Assist Prof Dr. AYŞEGÜL KILIÇLI at mus alparslan university, Turkeys

PROFILE  

scopus

Orcid

 

Early Academic Pursuits 🎓

Assist. Prof. Dr. Ayşegül KILIÇLI embarked on her academic journey with a profound dedication to the field of nursing, focusing specifically on obstetrics and gynecology. She earned her Bachelor’s degree in Nursing from a reputable institution, where her commitment to the healthcare field began to shine. Driven by a desire to enhance her expertise and contribute significantly to her field, she pursued a Master’s degree in Obstetric and Gynecology Nursing. This was followed by rigorous research and a doctoral degree (Ph.D.) in the same domain, equipping her with advanced knowledge and research skills essential for a successful academic and professional career.

Professional Endeavors 👩‍⚕️

Dr. KILIÇLI is currently serving as an Assistant Professor in the Obstetric and Gynecology Nursing Department at Muş Alparslan University Health Sciences Faculty. Her role involves teaching, mentoring, and guiding students through their academic and clinical experiences. Her professional journey reflects a commitment to advancing nursing education and practice. She is actively involved in several research projects and has published extensively in high-impact journals. Her work focuses on improving healthcare practices and patient outcomes, particularly in the field of obstetrics and gynecology.

Contributions and Research Focus 🔬

Dr. KILIÇLI’s research is primarily concentrated on obstetric and gynecology nursing. One of her notable completed research projects is a randomized controlled trial examining the effect of neurolinguistic programming and progressive muscle relaxation exercises on breastfeeding success and self-efficacy. This innovative study has been instrumental in advancing knowledge about non-pharmacological interventions in maternal care. Her research contributions are reflected in her publications in SCI-E journals, where her work is highly regarded by the scientific community.

Accolades and Recognition 🏆

Dr. KILIÇLI’s research excellence and contributions to the field have earned her recognition in various forums. Her work has been cited in prestigious databases, including Science Citation Index-Expanded (SCI-E), Scopus, and Web of Science (ESCI). She is celebrated for her significant contributions to advancing obstetric and gynecology nursing practices. Her role as a corresponding researcher further highlights her leadership and expertise in the field, establishing her as a respected figure in the global research community.

Impact and Influence 🌍

Dr. KILIÇLI’s impact extends beyond her research and academic contributions. Her work has positively influenced clinical practices, particularly in improving breastfeeding outcomes and maternal self-efficacy. By integrating innovative approaches into her research, she has contributed to the development of more effective strategies in nursing care. Her influence is also evident in the academic and professional growth of her students, who benefit from her extensive knowledge and mentorship.

Legacy and Future Contributions 🔮

As a pioneering researcher in obstetric and gynecology nursing, Dr. KILIÇLI is poised to leave a lasting legacy in her field. Her dedication to advancing maternal and child health through research and education is commendable. Looking ahead, Dr. KILIÇLI plans to continue her research with a focus on exploring new interventions and improving existing practices. Her future contributions are expected to further enhance nursing care practices and patient outcomes, reinforcing her position as a leading expert in her field.

🎓Publication 

The effect of neurolinguistic programming and progressive muscle relaxation exercises on breastfeeding success and breastfeeding self-efficacy: A randomized controlled trial

  • Authors   :Kiliçli, A., Gül, S.
  • Journal    :Explore
  • Year         :2024

Effect of Reflexology on Pain, Fatigue, Sleep Quality, and Lactation in Postpartum Primiparous Women After Cesarean Delivery: A Randomized Controlled Trial

Stress, Anxiety, and Postpartum Depression in Parents with Premature Infants in Neonatal Intensive Care Unit

Stigmatizing attitudes, beliefs, and actions of women towards abortion in rural regions with high fertility

Women’s reproductive behaviour and perspectives on fertility, and their modifying factors, in a Turkish province with a high fertility rate

Dr. Amrendra Ajay|Cardiovascular disease| Best Researcher Award

Posted on by sciencefather

Dr. Amrendra Ajay|Cardiovascular |Best Researcher Award|

Dr. Amrendra Ajay at Brigham and Women’s Hospital, Harvard, United States

PROFILE  

scopus

Orcid

 

Early Academic Pursuits 🎓

Amrendra Ajay’s academic journey began at B.N. College, Patna University, where he earned a Bachelor of Science degree in Biotechnology in 2002. His early focus on biotechnology laid a strong foundation for his future research endeavors. Eager to expand his knowledge, he pursued a Master of Science in Biotechnology at the prestigious Indian Institute of Technology (IIT), Bombay. The advanced curriculum and exposure to cutting-edge research during this period further fueled his interest in the field of biotechnology and biomedical sciences.

Ajay’s passion for research led him to the National Centre for Cell Science (NCCS) at Pune University, where he undertook his doctoral studies. His Ph.D. research centered on cancer biology, specifically focusing on chemotherapeutic drug-induced cell signaling in in vivo mouse models of cervical carcinoma. This research provided Ajay with a deep understanding of molecular biology and cancer research, setting the stage for his future work in kidney disease.

Professional Endeavors and Contributions 🧑‍🔬

Upon completing his Ph.D., Ajay transitioned to Harvard Medical School in Boston, where he embarked on a postdoctoral fellowship in 2010. His postdoctoral research was a pivotal period in his career, during which he delved into the mechanisms of acute kidney injury (AKI) and its progression to chronic kidney disease (CKD). This research was significant as it addressed a critical area in nephrology, focusing on how acute kidney injury could lead to long-term chronic conditions, a transition that was not fully understood at the time.

Ajay’s work involved the use of knockout mouse models to study molecular signaling pathways. He made significant contributions by showing how changes in molecular signaling could protect against acute kidney injury. One of his notable findings was the role of checkpoint kinase 1 (Chk1) in mediating the phosphorylation of STAT3, a transcription factor, which in turn regulated the expression of kidney injury molecule-1 (KIM-1), a key marker in kidney injury.

Since 2017, Ajay has held the position of Instructor in Medicine at Harvard Medical School and Associate Biologist at Brigham and Women’s Hospital. In these roles, he has continued his research on kidney diseases, focusing on the molecular mechanisms that drive the progression from acute to chronic kidney disease. His work has included the study of DPF3, an epigenetic regulator, and its role in chromatin remodeling and gene expression during kidney disease progression.

Research Focus and Impact 🔬

Ajay’s research has consistently aimed at unraveling the molecular underpinnings of kidney diseases, with a particular focus on the transition from acute kidney injury to chronic kidney disease. His work has identified several key molecular players, such as STAT3 and fibrinogen, which are involved in this progression. By understanding these mechanisms, Ajay’s research has opened new avenues for therapeutic interventions that could potentially prevent or slow down the progression of kidney diseases.

One of the groundbreaking aspects of his research was the discovery that the kidney itself synthesizes fibrinogen, a protein traditionally associated with blood clotting. Ajay demonstrated that a reduction in fibrinogen levels could protect against kidney injury, providing a new target for therapeutic intervention. Additionally, his work on STAT3 in pericytes revealed its role in kidney fibrosis, further contributing to the understanding of how chronic kidney disease develops.

Ajay has also contributed to cancer research, particularly in understanding how chemotherapeutic drugs induce molecular signaling in tumors. His work on p53, a crucial tumor suppressor protein, and its phosphorylation by cyclin-dependent kinase 5 (Cdk5) has provided insights into how cancer cells respond to chemotherapy, potentially leading to more effective treatment strategies.

Accolades and Recognition 🏆

Throughout his career, Ajay has received numerous awards and honors, reflecting the impact and significance of his research. He was honored with the Cardio-Renal Oral Presentation Award by the Department of Medicine at Brigham and Women’s Hospital in 2018, and he has received multiple best poster presentation awards from the Society of Toxicology. These accolades underscore his contributions to the fields of nephrology and toxicology.

His research excellence has also been recognized through prestigious grants and fellowships, including the CRISPR Innovation Award, which supports his ongoing work in gene editing to understand and potentially treat kidney fibrosis. His leadership in research is further evidenced by his successful mentorship of undergraduate students and postdoctoral fellows, who have gone on to make their own contributions to science.

Legacy and Future Contributions 🌟

Ajay’s work has had a profound impact on the understanding of kidney diseases and cancer biology. His research has not only advanced the scientific community’s knowledge but has also paved the way for the development of new therapeutic strategies that could improve patient outcomes. As he continues his work at Harvard Medical School, Ajay is poised to make further contributions to the field, particularly in the areas of epigenetics and the molecular mechanisms of disease progression.

Looking forward, Ajay’s research will likely continue to focus on the intersection of molecular biology and disease, with an emphasis on translating basic scientific discoveries into clinical applications. His ongoing projects, including those funded by the NIH and other prestigious organizations, are expected to yield new insights into the prevention and treatment of kidney diseases, thereby cementing his legacy as a leader in the field of nephrology and biomedical research.

Conclusion 🌐

Amrendra Ajay’s career is marked by a relentless pursuit of knowledge and a commitment to advancing the understanding of complex diseases. His contributions to nephrology, cancer research, and immunology have had a lasting impact on these fields. As he continues to explore new research avenues, Ajay’s work will undoubtedly lead to further scientific breakthroughs and innovations that could change the way we approach the treatment of chronic diseases.

🎓Publication 

Local vascular Klotho mediates diabetes-induced atherosclerosis via ERK1/2 and PI3-kinase-dependent signaling pathways

  • Authors   :Ajay, A.K., Zhu, L.-J., Zhao, L., … Shah, S.I., Hsiao, L.-L.
  • Journal    :Atherosclerosis
  • Year         :2024

TLR2 and TLR9 Blockade Using Specific Intrabodies Inhibits Inflammation-Mediated Pancreatic Cancer Cell Growth

  • Authors   :Ajay, A.K., Gasser, M., Hsiao, L.-L., Böldicke, T., Waaga-Gasser, A.M.
  • Journal    :Antibodies
  • Year         :2024

Survival, growth and digestive functions after exposure to nanodiamonds – Transgenerational effects beyond contact time in house cricket strains

  • Authors   :Augustyniak, M., Ajay, A.K., Kędziorski, A., … Wiśniewska, K., Ziętara, P.
  • Journal    :Chemosphere
  • Year         :2024

Personalized Therapeutics

  • Authors   :Peer, G.D.G., Saini, A., Vibhuti, A., Ajay, A..
  • Journal    :Nanotherapeutics for Inflammatory Arthritis: Design, Diagnosis, and Treatment,
  • Year         :2024

Putting transcriptional brakes on fibrosis: a negative regulator of TGFβ signaling

  • Authors   :Rohil, A., Talekar, S., Shammas, K.M., Ajay, A.K.
  • Journal    :Trends in Cell Biology
  • Year         :2024